Dr. Reddy’s Secures DCGI Nod for Zytorvi®️ (Toripalimab) to Treat Advanced Esophageal Cancer
Dr. Reddy’s Laboratories has received approval from the Central Drugs Standard Control Organisation (CDSCO), under the Drugs Controller General of India (DCGI) for Zytorvi® (toripalimab), in combination with cisplatin...
Abbott to Spin Off $8.5 Billion Nutrition Business Into Separate Public Company by the End of 2027
Abbott Laboratories has announced plans to separate its global Nutrition business into an independent, publicly traded company, creating a new entity with approximately $8.5 billion...
AstraZeneca and Oracle Join Forces to Make Clinical Trials Smarter With AI
AstraZeneca has partnered with Oracle to explore the use of artificial intelligence (AI) and real-world health data to improve clinical trial recruitment, strengthen safety monitoring...
FDA Approves GSK’s Jemperli as Immunotherapy Option for Certain Rectal Cancer Patients
The US Food and Drug Administration (FDA) has granted accelerated approval to GlaxoSmithKline’s (GSK) Jemperli(dostarlimab-gxly) as a standalone treatment for adults with previously untreated stage...
Eli Lilly Strikes $1.1 Billion AI Drug Delivery Deal With Metis TechBio
US pharmaceutical giant Eli Lilly has entered into a collaboration agreement worth up to $1.1 billion with Hong Kong-listed biotechnology company Metis TechBio to develop next-generation...
Merck KGaA of Germany Bets $1.3 Billion on Silence Therapeutics to Expand RNA Drug Pipeline
German pharmaceutical and life sciences company Merck KGaA has entered into a definitive agreement to acquire UK-based biotechnology firm Silence Therapeutics in an all-cash transaction...